Combination Therapy

Longer Therapy Better for Patients Who Suffer Hepatitis C Relapse

Published in Hepatitis Weekly, October 30th, 2000

Longer durations of combination therapy can successfully treat hepatitis C virus (HCV) patients who relapse after an initial round of treatment with interferon, especially if they initially have high levels of viral RNA or are of HCV genotype Ib.

Researchers reported this finding in the Journal of Hepatology ("Combined treatment of relapse of chronic hepatitis C with high-dose a(2)b interferon plus ribavirin for 6 or 12 months," J Hepatol, 2000;33(3):456-462).

Fifty HCV patients considered to be relapsers of alpha-interferon (IFN) therapy were chosen to participate in a trial where they were given additional doses of combination...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2000-10-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry